Xeltis is Trialing its Polymer-based Vascular Access

aXess is a self-healing device that allows the patient’s cells to colonize a polymeric matrix which then becomes an access. A U.S. trial has started enrolling patients. The FDA granted Xeltis Breakthrough Device Designation status.

Read the full article » | Posted 03-12-2026

Related Articles

• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026
• HollyTM Implantable Continuous Dialysis System Could be Ready for Human Trials Soon Posted 04-14-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
• Emerging Biomarker Research in PD Posted 03-12-2026